These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3728177)

  • 1. Allopurinol-1-riboside formation and HGPRT-deficiency.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():447-51. PubMed ID: 3728177
    [No Abstract]   [Full Text] [Related]  

  • 2. On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.
    Reiter S; Simmonds HA; Webster DR; Watson AR
    Biochem Pharmacol; 1983 Jul; 32(14):2167-74. PubMed ID: 6409116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary oxipurinol-1-riboside excretion and allopurinol-induced oroticaciduria.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():453-60. PubMed ID: 3728178
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside.
    Nishida Y; Kamatani N; Tanimoto K; Akaoka I
    Agents Actions; 1979 Dec; 9(5-6):549-52. PubMed ID: 121041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use and abuse of allopurinol in renal failure, the tumour lysis syndrome and HGPRT deficiency.
    Cameron JS; Simmonds HA; Morris GS
    Adv Exp Med Biol; 1986; 195 Pt A():435-40. PubMed ID: 3728175
    [No Abstract]   [Full Text] [Related]  

  • 6. Are allopurinol and metabolites found in HPRT deficient erythrocytes responsible for increased NAD synthesis?
    Micheli V; Jacomelli G; Sestini S; Notarantonio L; Cerboni B; Peruzzi L; Pompucci G
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1189-91. PubMed ID: 15571228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazolopyrimidine metabolism in Leishmania: an overview.
    Marr JJ
    Adv Exp Med Biol; 1984; 165 Pt A():231-7. PubMed ID: 6720385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of allopurinol riboside.
    Shapiro TA; Were JB; Danso K; Nelson DJ; Desjardins RE; Pamplin CL
    Clin Pharmacol Ther; 1991 May; 49(5):506-14. PubMed ID: 2029827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxanthine and xanthine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase (HPRT) deficiency.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Castroviejo IP; Vázquez JO
    Adv Exp Med Biol; 1989; 253A():173-9. PubMed ID: 2624187
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative metabolism of a new antileishmanial agent, allopurinol riboside, in the parasite and the host cell.
    Nelson DJ; LaFon SW; Elion GB; Marr JJ; Berens RL
    Adv Exp Med Biol; 1979; 122B():7-12. PubMed ID: 546162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial action of 4-thiopyrazolo (3.4-d) pyrimidine and its ribonucleoside. Biological effects and metabolism.
    Marr JJ; Berens RL; Nelson DJ; Krenitsky TA; Spector T; LaFon SW; Elion GB
    Biochem Pharmacol; 1982 Jan; 31(2):143-8. PubMed ID: 7073876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal hypoxanthine and ammonia release from working muscle in partial HPRT deficiency.
    Gross M; Gathof BS; Gresser U
    Adv Exp Med Biol; 1994; 370():345-8. PubMed ID: 7660924
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of dietary purines on the metabolism of allopurinol in man.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    World Rev Nutr Diet; 1984; 43():187-91. PubMed ID: 6475097
    [No Abstract]   [Full Text] [Related]  

  • 15. Partial hypoxanthine-guanine phosphoribosyl transferase deficiency without elevated urinary hypoxanthine excretion.
    van Dael CM; Pierik LJ; Reijngoud DJ; Niezen-Koning KE; van Diggelen OP; van Spronsen FJ
    Mol Genet Metab; 2007 Feb; 90(2):221-3. PubMed ID: 17129743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
    Torres RJ; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of hypoxanthine:guanine phosphoribosyltransferase activity in murine Dunn osteosarcoma.
    Abelson HT; Gorka C
    Cancer Res; 1983 Sep; 43(9):4098-101. PubMed ID: 6575863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probenecid on the pharmacokinetics of allopurinol riboside.
    Were JB; Shapiro TA
    Antimicrob Agents Chemother; 1993 May; 37(5):1193-6. PubMed ID: 8517715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesch-Nyhan syndrome: biochemical characterization of a case with attenuated behavioral manifestation.
    Fattal A; Spirer Z; Zoref-Shani E; Sperling O
    Enzyme; 1984; 31(1):55-60. PubMed ID: 6201351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: study of 12 cases].
    García Puig J; Mateos FA; Jiménez ML; Arcas J; Miranda ME; Oríz Vázquez J
    Med Clin (Barc); 1994 May; 102(18):681-7. PubMed ID: 8028417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.